BioNTech SE Adjustments For Finance Income
BioNTech SE (BNTX) reported Adjustments For Finance Income of EUR 423.90 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-10.
Financial Statements › Income Statement › Other Income
ifrs-full:AdjustmentsForFinanceIncome · last filed 2026-03-10
| Period end | Adjustments For Finance Income 12 month | Adjustments For Finance Income 12 month as first filed |
|---|---|---|
| 2025-12-31 | 423.90M EUR 20-F · filed 2026-03-10 | |
| 2024-12-31 | 648.50M EUR 20-F · filed 2026-03-10 | |
| 2023-12-31 | 519.60M EUR 20-F · filed 2026-03-10 | |
| 2022-12-31 | 265.30M EUR 20-F · filed 2025-03-10 | |
| 2021-12-31 | 1.50M EUR 20-F · filed 2024-03-20 | |
| 2020-12-31 | 1.60M EUR 20-F · filed 2023-03-27 | 1.56M EUR 20-F · filed 2021-03-30 |
| 2019-12-31 | 1.80M EUR 20-F/A · filed 2022-10-26 | 1.78M EUR 20-F · filed 2020-03-31 |
| 2018-12-31 | 2.00M EUR 20-F · filed 2021-03-30 | |
| 2017-12-31 | 2.13M EUR 20-F · filed 2020-03-31 |